Cargando…
Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
COVID-19, caused by SARS-CoV-2 infection, is currently among the most important public health concerns worldwide. Although several effective vaccines have been developed, there is an urgent clinical need for effective pharmaceutical treatments for treatment of COVID-19. Ivermectin, a chemical deriva...
Autores principales: | Uematsu, Takayuki, Takano, Tomomi, Matsui, Hidehito, Kobayashi, Noritada, Ōmura, Satoshi, Hanaki, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127164/ https://www.ncbi.nlm.nih.gov/pubmed/37185581 http://dx.doi.org/10.1038/s41429-023-00623-0 |
Ejemplares similares
-
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022) -
LYMPHOCYTIC CHORIOMENINGITIS IN THE SYRIAN HAMSTER
por: Smadel, J. E., et al.
Publicado: (1942) -
The Experimental Use of Syrian Hamsters
por: Valentine, Helen, et al.
Publicado: (2012) -
Ivermectin and malaria control
por: Ōmura, Satoshi, et al.
Publicado: (2017) -
Oral administration of heat-killed Lactobacillus kunkeei YB38 improves murine influenza pneumonia by enhancing IgA
production
por: ASAMA, Takashi, et al.
Publicado: (2016)